NBTX (Nanobiotix) EBITDA Margin %: -248.83% (As of Dec. 2025)


NBTX Nanobiotix SA NBTX
24 GF Score
Price $34.43
! 3 Warning Signs
View Full Analysis

What is Nanobiotix EBITDA Margin %?

Nanobiotix NBTX +3.18% 24 EBITDA Margin % is -248.83% as of Dec. 2025. GuruFocus rates NBTX with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 945 Biotechnology companies, Nanobiotix ranks better than 54.07% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nanobiotix's EBITDA for the six months ended in Dec. 2025 was $-13.74 Mil. Nanobiotix's Revenue for the six months ended in Dec. 2025 was $5.52 Mil. Therefore, Nanobiotix's EBITDA margin for the quarter that ended in Dec. 2025 was -248.83%.

Nanobiotix  (NAS:NBTX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Nanobiotix EBITDA Margin % Related Terms

Nanobiotix EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Nanobiotix's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanobiotix EBITDA Margin % Chart

Nanobiotix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -459,854.55 0.00 -100.09 502.37 -40.71

Nanobiotix Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.78 -277.13 232.07 -1.35 -248.83

NBTX vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Nanobiotix's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanobiotix EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanobiotix's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Nanobiotix's EBITDA Margin % falls into.


NBTX
24GF Score
Nanobiotix SA NBTX
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanobiotix EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Nanobiotix's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-14.131/34.711
=-40.71 %

Nanobiotix's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-13.738/5.521
=-248.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -248.83% mean?
Nanobiotix (NBTX) has a EBITDA Margin % of -248.83% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nanobiotix and its competitors. According to the industry distribution chart, Nanobiotix ranks #434 out of 945 companies in the Biotechnology industry, placing it in the top 45.9%.
Is Nanobiotix's EBITDA Margin % too high?
Nanobiotix's current EBITDA Margin % is -248.83%. Based on the distribution chart, Nanobiotix ranks #434 out of 945 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Nanobiotix has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Nanobiotix's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nanobiotix ranks #434 out of 945 companies for EBITDA Margin %. This puts Nanobiotix in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nanobiotix and its competitors. Nanobiotix's current EBITDA Margin % is -248.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanobiotix stock overvalued right now?
Nanobiotix (NBTX) has a current EBITDA Margin % of -248.83%. The current EBITDA Margin % is -248.83%. Nanobiotix's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Nanobiotix (NBTX), the current EBITDA Margin % is -248.83% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nanobiotix Business Description

Address 60 Rue de Wattignies, Paris, FRA, 75012
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
24GF Score

Get the complete analysis for NBTX

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.43
Price